Frequently Asked Questions
Lantus (insulin glargine) is a long-acting basal insulin analog. It is absorbed slowly from the subcutaneous injection site and provides steady insulin levels for approximately 24 hours. Unlike short-acting insulins that cover meals, basal insulin like Lantus provides the background insulin needed between meals and overnight. It works by lowering blood glucose through increased glucose uptake by cells and decreased glucose production by the liver. Lantus is used in both Type 1 and Type 2 diabetes management.
For Type 1 diabetes, a common starting dose is 0.2-0.3 units per kilogram of body weight per day. For Type 2 diabetes, a standard approach is 10 units once daily, or 0.1-0.2 units/kg/day. The actual starting dose must be individualized by a healthcare provider based on the patient's clinical presentation, glycemic control, and presence of other medical conditions. This calculator provides an educational estimate; prescribers should adjust based on clinical judgment and patient factors.
For most non-pregnant adults with diabetes, the target fasting blood glucose is 80-110 mg/dL according to American Diabetes Association recommendations. Some individuals may have individualized targets set by their healthcare provider. Elderly patients or those with hypoglycemia unawareness may have higher targets (100-130 mg/dL or greater) to reduce hypoglycemia risk. Pregnant women have stricter targets (60-99 mg/dL fasting). Always follow your prescriber's specific glucose targets.
Dose adjustments should typically be made every 3-7 days after observing a pattern of fasting glucose readings. Making changes too frequently can lead to oscillation and poor glycemic control. Guidelines recommend using an average of 2-3 days of fasting glucose readings before adjusting. Each dose change should be 2-4 units for established patients. More frequent or larger adjustments may increase hypoglycemia risk. Always consult your healthcare provider before making changes.
There is no absolute maximum dose of Lantus; doses up to 100+ units daily are used in insulin-resistant patients. However, the practical maximum for a single injection is typically 40 units due to injection volume and subcutaneous absorption constraints. Doses exceeding 40 units should generally be split into two injections (e.g., 25 units in morning, 20 units in evening). Split dosing improves absorption and glucose control. Prescribers adjust doses individually based on patient response.
Lantus should be injected once daily at approximately the same time each day. The time can be in the morning or evening—what matters most is consistency. Because Lantus has a 24-hour duration, it provides steady insulin levels when given at the same time daily. If you need to change your injection time, do so gradually (one hour earlier or later per day) to avoid glucose variability. Always consult your healthcare provider before changing your injection schedule.
Hypoglycemia (low blood sugar) symptoms include shakiness, sweating, rapid heartbeat, anxiety, hunger, tingling around the mouth, and difficulty concentrating. Severe hypoglycemia can cause confusion, loss of consciousness, or seizures. Mild-to-moderate hypoglycemia is treated with 15 grams of fast-acting carbohydrates (juice, glucose tablets, candy). After treating, recheck blood glucose in 15 minutes and repeat if necessary. Carry medical identification and teach family/friends to recognize and treat severe hypoglycemia. Discuss hypoglycemia prevention and glucagon use with your prescriber.
Lantus is administered via subcutaneous injection using a pen device or vial and syringe. Approved injection sites include the abdomen, thighs, and upper arms. Rotate injection sites with each dose to prevent lipohypertrophy (fat lumps). Never inject directly into areas with lumps, hardness, or swelling. Allow insulin to reach room temperature before injecting; cold insulin may be uncomfortable and slower to absorb. Clean skin with an alcohol swab but allow it to dry before injecting. Proper injection technique is essential; ask your healthcare provider or diabetes educator to observe your technique.
The most common side effect of Lantus is hypoglycemia (low blood sugar), especially when combined with rapid-acting insulins or other diabetes medications. Injection site reactions (redness, swelling, itching) occur in some patients but usually resolve with continued use at different injection sites. Weight gain is common with insulin therapy due to improved glucose control and anabolic effects. Rare but serious side effects include allergic reactions (rash, difficulty breathing) and hypokalemia (low potassium). Report any unusual symptoms to your healthcare provider immediately.
Unopened Lantus pens should be stored in a refrigerator at 2-8°C (36-46°F) until the expiration date. Once opened, a Lantus pen can be stored at room temperature (up to 30°C/86°F) for up to 28 days, even if it remains in the refrigerator. Do not freeze Lantus or expose it to direct heat or sunlight, as this destroys the insulin. Always inspect Lantus before use; it should be clear and colorless. If cloudy, frozen, or discolored, discard it. When traveling, use an insulated case to protect insulin from extreme temperatures.
What Is the Lantus Dosing Calculator?
The Lantus dosing calculator is a free clinical reference tool that estimates insulin glargine (Lantus) doses for adults with type 1 and type 2 diabetes. It uses two evidence-based algorithms: a weight-based starting dose for patients new to basal insulin, and a treat-to-target titration algorithm for patients adjusting an existing dose based on fasting blood glucose readings.
Endocrinologists, primary care providers, and certified diabetes educators use this tool as a quick reference during consultations. Patients and caregivers can use it to understand the math behind their prescription — though all dose changes must be confirmed with a licensed prescriber before they're implemented.
The calculations follow the ADA Standards of Medical Care in Diabetes 2026 and the Endocrine Society Clinical Practice Guideline on Insulin Therapy. Both organizations endorse weight-based starting doses (0.1–0.3 units/kg for type 2 diabetes, 0.2–0.4 units/kg for type 1 diabetes) and a structured titration protocol targeting fasting glucose of 80–130 mg/dL.
Whether you're a patient starting Lantus for the first time or a clinician reviewing a titration schedule, this tool surfaces the recommended dose instantly — along with a safety check for doses exceeding 40 units. Learn more about our clinical methodology and editorial standards.
Insulin Glargine Dosing: A Clinical Overview
Why Basal Insulin Matters
The liver produces glucose around the clock — even during fasting — through a process called hepatic glucose output. In people with diabetes, this process goes unchecked without adequate basal insulin coverage. Insulin glargine (Lantus) provides a steady, low-level insulin presence over approximately 20–24 hours that suppresses this overnight glucose production and keeps fasting readings in range.
Without adequate basal coverage, morning fasting glucose is consistently elevated — a pattern called the "dawn phenomenon." Patients often wonder why their glucose is higher in the morning than before bed; this is usually a sign that their Lantus dose needs adjustment. Getting basal insulin right is the foundation of any insulin regimen — bolus corrections at meals are far less effective when fasting glucose is already elevated.
Starting Dose Principles for New Patients
The ADA recommends two acceptable approaches for starting type 2 patients on basal insulin: a fixed dose of 10 units per day, or a weight-based dose of 0.1–0.2 units/kg. For most patients under 75 kg, the 10-unit fixed start is preferred because it's simple, carries a low hypoglycemia risk, and can be titrated up quickly. For patients above 100 kg, the weight-based approach is usually more appropriate — 10 units would provide inadequate coverage from the start.
Type 1 patients starting Lantus typically need higher starting doses — 0.2–0.4 units/kg — because their total daily insulin requirement is primarily covered by the basal component in the absence of any endogenous production. Most type 1 adults require 40–50% of their total daily dose from basal insulin and 50–60% from rapid-acting bolus coverage at meals.
Titration: Adjusting Your Dose Over Time
The most widely used titration protocol — sometimes called the "3-3-3 rule" or the INSIGHT algorithm — adjusts the Lantus dose every 3 days based on the average of the 3 most recent fasting glucose readings. If the average is above 130 mg/dL, increase by 2 units. If any single reading was below 70 mg/dL in the past 3 days, do not increase — and consider decreasing by 2–4 units.
Patients often make the mistake of adjusting too frequently. Lantus has a long half-life; it takes about 3 days to reach steady-state at a new dose. Adjusting daily based on a single reading creates an unstable cycle of over- and under-correction. The 3-day waiting period is not arbitrary — it's pharmacologically grounded.
When to Involve Your Care Team
Self-titration with a structured protocol is safe and effective for most patients with stable diabetes. But several situations require direct involvement of a physician or certified diabetes educator before adjusting:
- Recommended dose exceeds 40 units (typically requires splitting into two injection sites or transitioning to a different regimen)
- Hypoglycemia episodes (readings below 70 mg/dL) occurring more than twice per week
- A1C has not improved after 3 months of optimized Lantus therapy — this may indicate a need for bolus insulin coverage
- Pregnancy, kidney disease, or recent hospitalization — all alter insulin sensitivity significantly
- Any unexplained hypoglycemia, particularly nocturnal episodes
The American Diabetes Association and Endocrine Society both publish annual updates to their clinical practice guidelines — these are the primary sources this calculator is based on.
Who Should Use This Calculator?
This Lantus dosing calculator is designed for a range of users — from patients self-managing their insulin to clinicians who want a quick titration reference during patient visits.
- Type 2 diabetics starting basal insulin: If your doctor has just prescribed Lantus and you want to understand the reasoning behind the starting dose, this tool walks you through the weight-based calculation step by step.
- Type 1 diabetics on a multiple daily injection (MDI) regimen: Use the titration function to check whether your current Lantus dose aligns with published guidelines based on your recent fasting glucose patterns.
- Endocrinologists and primary care providers: A fast reference for dose calculations during busy office visits or telehealth consultations — especially useful when reviewing patient-reported fasting glucose logs.
- Certified diabetes educators (CDEs) and diabetes care and education specialists (DCES): Use this tool in patient education sessions to demonstrate how the treat-to-target algorithm works in practice.
- Caregivers and family members: Managing insulin for an elderly parent or child with diabetes? This calculator helps you understand the dose rationale so you can ask more informed questions at appointments.
- Nursing and pharmacy students: A practical reference for learning clinical insulin dosing algorithms alongside pharmacology coursework.
This tool gives you an estimate based on published clinical guidelines. It doesn't account for individual variation, comorbidities, or drug interactions. Always confirm dose changes with the prescribing provider before injecting.
ToolSite Team
We build free, accurate calculators.